Similarly, in an in vitro and in vivo analysis of triple negative breast cancers (TNBC), reversal of EMT progression by DNA methyltransferase and histone deacetylase inhibitor treatment, decreased EpCAM cleavage and nuclear signaling with TCF4 [63]. Here, EPCAM is linked to triple-negative breast carcinoma.